Beyond Medical Technologies Inc.
DOCT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.74% | -24.87% | 0.69% | -17.48% | -34.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.74% | -24.87% | 0.69% | -17.48% | -34.05% |
| Operating Income | 4.74% | 24.87% | -0.69% | 17.48% | 34.05% |
| Income Before Tax | 3.66% | 66.08% | 50.26% | 19.64% | 32.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.66% | 66.08% | 50.26% | 19.64% | 32.81% |
| Earnings from Discontinued Operations | -94.12% | 23.83% | 102.94% | 58.98% | 101.07% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.74% | 120.05% | 52.06% | 42.31% | 72.60% |
| EBIT | 4.74% | 24.87% | -0.69% | 17.48% | 34.05% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 1.06% | 120.20% | 52.38% | 42.48% | 72.75% |
| Normalized Basic EPS | 3.33% | 24.24% | 5.26% | 19.27% | 33.33% |
| EPS Diluted | 1.06% | 120.20% | 52.38% | 42.48% | 72.75% |
| Normalized Diluted EPS | 3.33% | 24.24% | 5.26% | 19.27% | 33.33% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
